Lung cancer prevention: Research and New Treatments on the Horizon

    New chemotherapy approaches: Clinical trials are currently investigating the use of neoadjuvant treatments (chemotherapy or a combination of chemotherapy and radiation,diagnosed by x ray machine before surgery) for early stage lung cancer. Other clinical trials are testing new chemotherapy drugs, while other studies are testing whether the effectiveness of existing chemotherapeutic drugs can be improved by combining them with each other or with radiation therapy (fluoroscopy on lung or take radiography via x ray equipment, surgical x ray system ).


      Vaccines, manufactured from the patient's own tumor cells or a protein common to lung cancer cells, are presently under investigation. They use the body's immune system to fight lung cancer. The goal is to cause the immune system to recognize some of the abnormal substances in lung cancer cells and as a result, kill these cells.


      Specially designed antibodies are being produced in the laboratory that can be injected into patients to seek out lung cancer cells. Toxins or radioactive atoms can be attached to these antibodies, so that the cell-killing chemicals or radiation is targeted specifically to the cancer cells, preventing destruction of healthy cells of the body. These specialized (monoclonal) antibodies are being studied in clinical trials alone and in combination with standard chemotherapy regimens.


      Special drugs called angiogenesis inhibitors are being studied in clinical trials, alone and in combination with standard chemotherapy regimens. These agents are designed to block the formation of blood vessels to the tumor, thereby starving and, hopefully, killing them.


      Small molecules are being designed to specifically target and interfere with some aspect of tumor cell function. One such example is an experimental compound called ZD1839 (Iressa), an inhibitor of the epidermal growth factor receptor (EGFR), which is present on the tumors of some patients with nonsmall-cell lung cancer.

The importance of after-sales service

      For most of country hospitals, there are several emphasis when they purchase large medical equipments, such as digital x ray machine, mobile x ray machine,mobile c arm x ray machine.    First, pay attention to system full function. It is also that one equipment can meet every department diversity demand; Second, high equipment stability and ensure long time of continuous operation: Third, input and output maximization by the least cost to get more features and value; Fourth, Guarantee service. Basic hospitals are lack of professional and technical person and so require manufacturers to provide better service on the basic of simple and convenient equipments.

     Obviously, country hospitals all increase medical equipment purchasing from medical reform. But equipment research and development is not enough. It doesn’t have after-service and training and this is main reason that country hospitals can purchase it but they won’t use it.

     Recently, after-sales service problems of basic medical equipments have already been one of the most concern. Most of enterprises only sell equipments and don't take charge training and maintenance.

      Basic medical market not only require medical equipment enterprises to offer simple and convenient device but also there are someone to fix it when equipments are broken. So after-sales service is key factor. At present, some products can realize network synchronization and instruct maintenance but there are hardware problems and need relevant person to solve it in time.

       According to experts, after-sales service importance will exceed sale when you get certain market share. Therefore your sales is accumulated and have to protect your customers by after-service and maintain customers.